5 unknown, 3 recruiting, 2 completed, 1 terminated. 11 Phase 2, 5 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Unknown 5, Recruiting 3, Completed 2, Terminated 1 |
| Phase 1 | 5 | Unknown 5 |
| Phase 3 | 1 | Completed 1 |
Follow Gadolinium: new trials by email Literature Review of Gadolinium trials Research Report on Gadolinium
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance MRI of the Brain, Blood draws, Quality of Life Questionnaires - Brain Metastases, Nonsmall Cell Lung Cancer Stage III | Phase 2 | Recruiting | Wake Forest University Health Sciences | 60 | 2023-08-30 | 2026-07-17 |
| CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma Gemcitabine, Dacarbazine, Cytoreductive Surgery - LMS - Leiomyosarcoma, Uterine Leiomyosarcoma | Phase 2 | Completed | Stanford University | 17 | 2021-01-28 | 2026-06-25 |
| Feasibility of FMISO in Brain Tumors ¹⁸F-Fluoromisonidazole, Computed Tomography, Magnetic Resonance Imaging - IDH Wild Type Glioblastoma | Phase 2 | Recruiting | OHSU Knight Cancer Institute | 77 | 2019-06-01 | 2026-09-18 |
| Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System Ferumoxytol, Gadolinium, Magnetic Resonance Imaging - Central Nervous System Neoplasm, Cranial Nerve Disorder | Phase 2 | Recruiting | OHSU Knight Cancer Institute | 150 | 2017-10-06 | 2026-09-14 |
| ASIS for Enbrel in Plaque Psoriasis Gadolinium, Efficacy of Enbrel subcutaneously at Week 12, Efficacy of Enbrel subcutaneously at Week 24 - Plaque Psoriasis. | Phase 1 / Phase 2 | Unknown | ASIS Corporation | 60 | 2016-01-01 | 2015-06-24 |
| ASIS for Botox in Chronic Migraine Gadolinium, Efficacy of Botox intramuscularly at Week 6, Efficacy of Botox intramuscularly at Week 12 - Chronic Migraine More than15 Days Per Month, and Lasting 4 Hours a Day or Longer. | Phase 1 / Phase 2 | Unknown | ASIS Corporation | 60 | 2016-01-01 | 2015-06-24 |
| ASIS for Botox in Upper Limb Spasticity Gadolinium, Efficacy of Botox intramuscularly at Week 6, Efficacy of Botox intramuscularly at Week 12, - Upper Limb Spasticity Unilaterally in Adults With History of Stroke, Increased Muscle Tone in Elbow, Wrist, Finger, and Thumb Flexors. | Phase 1 / Phase 2 | Unknown | li nguyen | 60 | 2016-01-01 | 2015-06-24 |
| ASIS for GAMMAGARD in Primary Immunodeficiency Gadolinium For abdomen, Gadolinium For lower back, Efficacy of Gammagard subcutaneously at Week 12 - Primary Immunodeficiency | Phase 1 / Phase 2 | Unknown | ASIS Corporation | 60 | 2016-01-01 | 2015-06-24 |
| ASIS for Botox in Cervical Dystonia Gadolinium, Efficacy of Botox intramuscularly at Week 6, Efficacy of Botox intramuscularly at Week 12 - Cervical Dystonia Adults ,, Abnormal Head Position and Neck Pain for These 7 Muscle Groups: Splenius,Scalene,Sterno-cleido-mastoid,Levator Scapulae,Semispinalis,Trapezius,and Longissimus. | Phase 1 / Phase 2 | Unknown | li nguyen | 60 | 2016-01-01 | 2015-06-24 |
| Comprehensive Evaluation of Ischemic Heart Disease Using MRI Gadolinium, Adenosine - Heart Disease, Ischemic, Atherosclerosis, Coronary | Phase 2 / Phase 3 | Completed | Northwestern University | 40 | 2010-06-01 | 2014-09-26 |
| Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain Tumors 3 Tesla Magnetic Resonance Imaging, Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging - Metastatic Malignant Neoplasm in the Brain, Primary Brain Neoplasm | Phase 2 | Terminated | OHSU Knight Cancer Institute | 40 | 2006-11-16 | 2023-09-07 |
Brain Neoplasms (3) · Carcinoma, Non-Small-Cell Lung (1) · Central Nervous System Neoplasms (1) · Coronary Artery Disease (1) · Cranial Nerve Diseases (1) · Myocardial Ischemia (1) · Primary Immunodeficiency Diseases (1) · Torticollis (1)
ASIS Corporation (3) · OHSU Knight Cancer Institute (3) · li nguyen (2) · Northwestern University (1) · Stanford University (1) · Wake Forest University Health Sciences (1)
United States (11)
Li Nguyen, MD (4) · Thanh Phung, MD (2) · Thanh Phung,, MD (2) · Edward Neuwelt (1) · Hanh Nguyen, MD (1) · James C Carr, MD (1) · Kristen N Ganjoo, MD (1) · Michael F Regner, MD (1) · Michael Farris, MD (1) · Ramon Barajas (1)
P30CA012197 (1), R01CA137488 (1), R37CA288577 (1)